CWM Advisors »

Zentalis Pharmaceuticals shares owned by CWM Advisors

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by CWM Advisors from 13F filings

Historical chart of CWM Advisors investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by CWM Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by CWM Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $22 16 1.38

More positions owned by CWM Advisors

Caterpillar (CAT)
Amphenol Corp Cl A (APH)
Kla Corp Com New (KLAC)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Northern Lts Fd Tr Iv Inspire Corp Bd (IBD)
Northern Lts Fd Tr Iv Inspire Intl Etf (WWJD)
Arista Networks Com Shs (ANET)
Progressive Corporation (PGR)
Welltower Inc Com reit (WELL)
Interactive Brokers Group In Com Cl A (IBKR)
Prologis (PLD)
Parker-Hannifin Corporation (PH)
Northern Lts Fd Tr Iv Inspire 500 Etf (PTL)
Monolithic Power Systems (MPWR)
Emcor (EME)

View all positions for CWM Advisors

Top funds holding Zentalis Pharmaceuticals

5AM Venture Management
Renaissance Technologies
Vanguard Group
Acadian Asset Management
Citadel Advisors
Two Sigma Advisers
D. E. Shaw & Co
Opaleye Management
Two Sigma Investments
Decheng Capital
BlackRock
Balyasny Asset Management
GSA Capital Partners
Tybourne Capital Management
PRIMECAP Management Company

View all funds holding Zentalis Pharmaceuticals